Gregory Cooksey Rigdon

Title: Gregory Cooksey Rigdon: Innovator in Pain Treatment

Introduction

Gregory Cooksey Rigdon is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pain treatment through his innovative methods and compounds. With a total of 4 patents to his name, Rigdon's work has the potential to impact many lives.

Latest Patents

Rigdon's latest patents include groundbreaking methods for treating or preventing pain. His invention relates to a novel method of treating pain using compounds that modulate KCNQ potassium channels and currents. Additionally, he has developed Gardos channel antagonists, which are novel inhibitors of potassium flux. These inhibitors demonstrate surprising resistance to degradation in biological media and enhanced in vivo half-lives compared to non-fluorine substituted homologues. The methods for using these compounds include treating sickle cell disease, preventing erythrocyte dehydration, and inhibiting potassium flux.

Career Highlights

Throughout his career, Rigdon has worked with prominent companies such as Icagen, Inc. and Glaxo Wellcome Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medical treatments.

Collaborations

Rigdon has collaborated with notable coworkers, including Grant Andrew McNaughton-Smith and James L Kelley. These partnerships have fostered a collaborative environment that encourages innovation and the development of new ideas.

Conclusion

Gregory Cooksey Rigdon's contributions to pain treatment through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for advancements in medical science and patient care.